BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 37330494)

  • 21. Cuproptosis-related gene
    Huang S; Cai C; Zhou K; Wang X; Wang X; Cen D; Weng G
    Aging (Albany NY); 2023 Nov; 15(21):12314-12329. PubMed ID: 37938155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma.
    Li Y; Zeng X
    Front Pharmacol; 2022; 13():1081952. PubMed ID: 36703728
    [No Abstract]   [Full Text] [Related]  

  • 23. Comprehensive analysis of a cuproptosis-related ceRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancer.
    Zhang D; Lu W; Zhuo Z; Wang Y; Zhang W; Zhang M
    BMC Med Genomics; 2023 May; 16(1):96. PubMed ID: 37143115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma.
    Chen Y; Lin X; Zou X; Qian Y; Liu Y; Wang R; Wang X; Yu X; Liu C; Cheng H
    BMC Gastroenterol; 2023 Apr; 23(1):113. PubMed ID: 37024802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive molecular analyses of cuproptosis-related genes with regard to prognosis, immune landscape, and response to immune checkpoint blockers in lung adenocarcinoma.
    Li R; Tong R; Zhang JL; Zhang Z; Deng M; Hou G
    J Cancer Res Clin Oncol; 2024 May; 150(5):246. PubMed ID: 38722401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cuproptosis-Related Genes MTF1 and LIPT1 as Novel Prognostic Biomarker in Acute Myeloid Leukemia.
    Li Y; Kan X
    Biochem Genet; 2024 Apr; 62(2):1136-1159. PubMed ID: 37561332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The signature of cuproptosis-related immune genes predicts the tumor microenvironment and prognosis of prostate adenocarcinoma.
    Yao K; Zhang R; Li L; Liu M; Feng S; Yan H; Zhang Z; Xie D
    Front Immunol; 2023; 14():1181370. PubMed ID: 37600770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel cuproptosis-related prognostic gene signature in adrenocortical carcinoma.
    Gao W; He X; Huangfu Q; Xie Y; Chen K; Sun C; Wei J; Wang B
    J Clin Lab Anal; 2023 Nov; 37(21-22):e24981. PubMed ID: 37997497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and validation of a novel cuproptosis signature for stratifying different prognostic, immune, metabolic, and therapeutic landscapes in pancreatic adenocarcinoma.
    Yan X; Zheng W; Xu FS; Chang HL; Zhang Y; Zhang ZY; Zhang YH
    Eur Rev Med Pharmacol Sci; 2024 Mar; 28(5):2024-2050. PubMed ID: 38497885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.
    Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C
    J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
    Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
    Front Immunol; 2022; 13():919231. PubMed ID: 35967366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
    Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
    Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
    Yan C; Niu Y; Li F; Zhao W; Ma L
    J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cuproptosis regulatory genes greatly contribute to clinical assessments of hepatocellular carcinoma.
    Ke C; Dai S; Xu F; Yuan J; Fan S; Chen Y; Yang L; Li Y
    BMC Cancer; 2023 Jan; 23(1):25. PubMed ID: 36611155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of novel potential homologous repair deficiency-associated genes in pancreatic adenocarcinoma via WGCNA coexpression network analysis and machine learning.
    Liu C; Fang J; Kang W; Yang Y; Yu C; Chen H; Zhang Y; Ouyang H
    Cell Cycle; 2023 Nov; 22(21-22):2392-2408. PubMed ID: 38124367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer.
    Jiang X; Ke J; Jia L; An X; Ma H; Li Z; Yuan W
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):203-218. PubMed ID: 36376617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Construction of Lung Adenocarcinoma Prognosis Model and Drug Sensitivity Analysis Based on Cuproptosis Related Genes].
    Sun J; Zhang H; Liu H; Dong Y; Wang P
    Zhongguo Fei Ai Za Zhi; 2023 Aug; 26(8):591-604. PubMed ID: 37752539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma.
    Tian X; Zhu S; Liu W; Wu X; Wei G; Zhang J; Anwaier A; Chen C; Ye S; Che X; Xu W; Qu Y; Zhang H; Ye D
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17451-17466. PubMed ID: 37889309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cuproptosis-related genes predict prognosis and trastuzumab therapeutic response in HER2-positive breast cancer.
    Sha R; Dong X; Yan S; Dai H; Sun A; You L; Guo Z
    Sci Rep; 2024 Feb; 14(1):2908. PubMed ID: 38316885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a 5-Gene Cuproptosis Signature Predicting the Prognosis for Colon Adenocarcinoma Based on WGCNA.
    Wang D; Yang F; Han G; Zhang J; Wang H; Xiao Z; Chen W; Li P
    Technol Cancer Res Treat; 2024; 23():15330338241250285. PubMed ID: 38802999
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.